PERCEPTIVE ADVISORS LLC — 13F Holdings & Portfolio
CIK 1224962 · latest 13F-HR filed 2026-05-29
PERCEPTIVE ADVISORS LLC manages $5.12B in 13F-reported U.S. long-equity assets across 94 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are PRAX (12.82%), CELC (6.97%), ASND (6.84%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 1, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$5.12B
Long-equity book
94
Distinct positions
2026-03-31
Filed 2026-05-29
+0 / −0 / ↑1 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $656.0M | 12.82% | 2,035,986 | SH |
| 2 | CELCUITY INC | CELC | 15102K100 | $356.9M | 6.97% | 3,127,200 | SH |
| 3 | ASCENDIS PHARMA A/S | ASND | 04351P101 | $350.3M | 6.84% | 1,531,421 | SH |
| 4 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $229.5M | 4.48% | 8,285,461 | SH |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 152309100 | $208.9M | 4.08% | 5,258,903 | SH |
| 6 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $206.4M | 4.03% | 2,373,795 | SH |
| 7 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $190.8M | 3.73% | 3,783,225 | SH |
| 8 | NUVALENT INC | NUVL | 670703107 | $161.9M | 3.16% | 1,580,505 | SH |
| 9 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $139.4M | 2.72% | 4,423,974 | SH |
| 10 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $129.7M | 2.54% | 1,230,879 | SH |
| 11 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $129.7M | 2.53% | 1,540,384 | SH |
| 12 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $123.1M | 2.40% | 4,142,551 | SH |
| 13 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $115.2M | 2.25% | 8,284,882 | SH |
| 14 | IMMATICS N.V | IMTX | N44445109 | $102.2M | 2.00% | 10,383,456 | SH |
| 15 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $97.0M | 1.90% | 9,751,141 | SH |
| 16 | INHIBRX BIOSCIENCES INC | INBX | 45720N103 | $97.0M | 1.90% | 1,442,707 | SH |
| 17 | MEIRAGTX HLDGS PLC | MGTX | G59665102 | $89.3M | 1.75% | 10,326,103 | SH |
| 18 | ZYMEWORKS INC | ZYME | 98985Y108 | $87.9M | 1.72% | 3,510,078 | SH |
| 19 | SOLID BIOSCIENCES INC | SLDB | 83422E204 | $85.7M | 1.68% | 11,906,646 | SH |
| 20 | DYNE THERAPEUTICS INC | DYN | 26818M108 | $84.6M | 1.65% | 4,668,839 | SH |
| 21 | BIOCRYST PHARMACEUTICALS INC | BCRX | 09058V103 | $70.8M | 1.38% | 7,434,033 | SH |
| 22 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $68.4M | 1.34% | 1,395,501 | SH |
| 23 | ARTIVION INC | AORT | 228903100 | $60.0M | 1.17% | 1,637,290 | SH |
| 24 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | $57.5M | 1.12% | 3,710,877 | SH |
| 25 | MODERNA INC Put | MRNA | 60770K107 | $50.8M | 0.99% | 1,000,000 | SH |
| 26 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 63909J108 | $48.9M | 0.95% | 12,594,211 | SH |
| 27 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $47.5M | 0.93% | 10,098,824 | SH |
| 28 | ALTO NEUROSCIENCE INC | ANRO | 02157Q109 | $45.2M | 0.88% | 2,009,893 | SH |
| 29 | ENGENE HOLDINGS INC | ENGNW | 29286M105 | $39.7M | 0.78% | 5,827,506 | SH |
| 30 | IMMUNOVANT INC | IMVT | 45258J102 | $39.7M | 0.78% | 1,597,383 | SH |
| 31 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $39.4M | 0.77% | 85,419 | SH |
| 32 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $37.8M | 0.74% | 504,000 | SH |
| 33 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 23954D109 | $37.6M | 0.74% | 1,755,799 | SH |
| 34 | ABIVAX SA | ABVX | 00370M103 | $36.6M | 0.72% | 328,884 | SH |
| 35 | CORVUS PHARMACEUTICALS INC | CRVS | 221015100 | $33.5M | 0.66% | 2,292,441 | SH |
| 36 | REPLIGEN CORP | RGEN | 759916109 | $33.1M | 0.65% | 280,541 | SH |
| 37 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $32.1M | 0.63% | 170,000 | SH |
| 38 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $31.7M | 0.62% | 1,223,000 | SH |
| 39 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $27.8M | 0.54% | 6,737,648 | SH |
| 40 | GUARDANT HEALTH INC | GH | 40131M109 | $27.7M | 0.54% | 300,000 | SH |
| 41 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $27.5M | 0.54% | 377,544 | SH |
| 42 | INVIVYD INC | IVVD | 00534A102 | $27.1M | 0.53% | 20,859,303 | SH |
| 43 | SIONNA THERAPEUTICS INC | SION | 829401108 | $26.4M | 0.52% | 658,439 | SH |
| 44 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $25.3M | 0.50% | 149,950 | SH |
| 45 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $25.1M | 0.49% | 258,600 | SH |
| 46 | SAB BIOTHERAPEUTICS INC | SABS | 78397T202 | $24.6M | 0.48% | 6,431,743 | SH |
| 47 | BELITE BIO INC | BLTE | 07782B104 | $24.2M | 0.47% | 151,979 | SH |
| 48 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $23.2M | 0.45% | 1,447,782 | SH |
| 49 | AXOGEN INC | AXGN | 05463X106 | $23.1M | 0.45% | 697,312 | SH |
| 50 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $22.9M | 0.45% | 1,170,829 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $5.11B | 94 | 0001012975-26-000443 |
| 2026-03-31 | 2026-05-29 | $5.12B | 94 | 0001012975-26-000499 |
| 2025-12-31 | 2026-02-17 | $5.61B | 116 | 0001012975-26-000155 |
| 2025-09-30 | 2025-11-14 | $3.46B | 93 | 0001012975-25-000762 |